About Establishment Labs
Establishment Labs is a publicly listed company based in Alajuela (Costa Rica) founded in 2010. Silicone-filled breast and body shaping implants are designed and manufactured. It operates on a B2B2C and HealthTech model. Establishment Labs has raised $121 million across 10 funding rounds from investors including Perceptive Advisors, Madryn Asset Management and Crown Predator Holdings. The company has 1,020 employees. Its chief executive, as recorded, is Juan Jose Chacon Quiros. Establishment Labs offers products and services including Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech. Its focus areas include Medical Devices and Surgical Implants. Its legal entity is Establishment Labs Holdings Inc.
Company details
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving womens health through innovative Femtech solutions. The company specializes in breast health, aesthetics, and reconstruction, offering products like Motiva SmoothSilk implants for augmentation and Motiva Flora tissue expanders for reconstruction following breast cancer. Additionally, Mia Femtech provides minimally invasive breast harmony solutions. Supported by over 200 patent applications and 50 scientific studies, their offerings are grounded in science-based innovation. The company operates in multiple regions, including Costa Rica, Brazil, and Belgium, targeting healthcare providers and patients in the medical and aesthetic sectors.
- Headquarters Alajuela, Costa Rica
- Employees 1,020
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website establishmentlabs.com
- Social LinkedIn
- Legal Name Establishment Labs Holdings Inc.
- Annual Revenue$211.08 M (USD)27.14as on Dec 31, 2025
- Net Profit-$51.06 M (USD)39.64as on Dec 31, 2025
- EBITDA-$28.53 M (USD)32.72as on Dec 31, 2025
- Total Equity Funding$121M (USD)
in 10 rounds
- Latest Funding Round$50M (USD), Post-IPO
Jan 2024
- InvestorsPerceptive Advisors
& 5 more
- Employee Count1,020
Products & Services of Establishment Labs
Establishment Labs offers a comprehensive portfolio of products and services, including Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech.
Breast implants used for aesthetic augmentation procedures.
Ergonomic implants designed for natural breast augmentation.
Tissue expander for breast reconstruction post-cancer surgery.
Minimally invasive solution for breast harmony aesthetics.
Funding Insights of Establishment Labs
Establishment Labs has successfully raised a total of $121M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $121M
- Total Rounds 10
- Last Round Post-IPO — $50M
- Investors Count 6
All 10 funding rounds of Establishment Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $50M | Post-IPO | – | – | – |
| Jan 2024 | $50M | Post-IPO | – | – | – |
| Jan 2024 | $50M | Post-IPO | – | – | – |
| Jun 2019 | $25M | Debt – Conventional | – | – | |
| Aug 2017 | $55M | Series D | – | – | |
| Feb 2017 | $18M | Series C | – | – | – |
| Sep 2016 | $15M | Debt – Conventional | – | – | |
| Jul 2016 | $28M | Series C | – | Crown Predator Holdings, Perceptive Advisors | – |
| Sep 2015 | $20M | Series B | – | – | |
| Sep 2013 | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Establishment Labs
Establishment Labs has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Perceptive Advisors, Madryn Asset Management and Crown Predator Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Single family office and private equity firm focused on healthcare, hedge funds, venture capital, and multiple sectors | crownpredator.com | New York, United States | ||
Investment services are offered in healthcare and cannabis sectors. | jwfunds.com | |||
| rioafrica.com | ||||
Diversified asset management is provided by the firm. | 2017 | madrynlp.com | New York, United States | |
| invermaster.com |
Investor details for Establishment Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Establishment Labs
86 people are tracked at Establishment Labs (30 in leadership, 7 in board & advisors, 49 in team); the tracked headcount is 1,020.
| Name | Role | Group |
|---|---|---|
Juan Jose Chacon Quiros | CEO | Leadership |
Juan José Chacón-Quirós | CEO & Founder | Leadership |
Raj Denhoy | CFO | Leadership |
Ross Mansbach | General Counsel & Chief Human Resources Officer | Leadership |
Maria Quintas | Head Of Global Sales | Leadership |
Anne Pugh | Head Of Sales | Leadership |
Oliver James | General Manager For Northern Europe | Leadership |
Gabriela Campos | Corp Quality Systems & Design QA Director | Leadership |
Danny Murphy | SOX Compliance Director | Leadership |
Vanessa Tello Oliva | Sr Director International Marketing | Leadership |
Milton Comin | Global Finance Planning Senior Director | Leadership |
Antonio Herrero | Director Manufacturing Operations | Leadership |
Rebeca Mejias | HRBP Edc, Talent & Payroll Partner EMEA | Leadership |
Paul Rodio | Chief Operating Officer | Leadership |
Ivan Bilic | Senior Vice President, Head Of Commercial OUS | Leadership |
Kristina Sarubbi | Director Of Finance | Leadership |
Jaime Pulido | Vice President / Global Controller | Leadership |
Virginie Schweitzer | Mia Commercial Director | Leadership |
John Liljequist | Commercial Head - Asia Pacific | Leadership |
Alejandro Hueda | VP of Operations | Leadership |
66 more people are available in the full profile.
Complete people profiles for Establishment Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Establishment Labs
Establishment Labs is a publicly listed company on the NASDAQ with ticker symbol ESTA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Jul 2018
- Listed onNASDAQ: ESTA
- Listed entityEstablishment Labs Holdings Inc.
- Exchange sectorHealth technology
- ISINVGG312491084
- Share price$58.45 (-5.16% on the day) · 2026-10-13
- Market capitalisation$1.74B
- EPS (diluted, trailing year)$-1.30
- Volume (last session)482,983
Financials of Establishment Labs
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $211.1M | -$51.1M | -$28.5M |
| 2024 | $166.0M | -$84.6M | -$42.4M |
| 2023 | $165.2M | -$78.5M | -$60.1M |
| 2022 | $161.7M | -$75.2M | -$35.5M |
| 2021 | $126.7M | -$41.1M | -$21.0M |
Detailed financial statements for Establishment Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Establishment Labs
4 dated milestones of Establishment Labs across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Establishment Labs is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $50.0M.
Web traffic of Establishment Labs
The website of Establishment Labs (establishmentlabs.com) receives about 7.1K visits a month.
- Monthly visits7.1K
▼ 13.6% vs previous month
Websites whose visitors overlap most with Establishment Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| motivaimplants.com | 100% | #10,923,715 | View details | ||
| multiestetica.com | 89% | 88K | #475,685 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Establishment Labs
Complete news archive for Establishment Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Establishment Labs
Establishment Labs was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Establishment Labs is headquartered in Alajuela, Costa Rica. It is registered at Alajuela, Alajuela, Costa Rica.
Juan Jose Chacon Quiros is the CEO of Establishment Labs, as recorded in our data.
Establishment Labs is a funded company, having raised a total of $121M across 10 funding rounds to date.
Establishment Labs has 1,020 employees.
Annual revenue of Establishment Labs is $211.08M as on Dec 31, 2025.
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving womens health through innovative Femtech solutions. The company specializes in breast health, aesthetics, and reconstruction, offering products like Motiva SmoothSilk implants for augmentation and Motiva Flora tissue expanders for reconstruction following breast cancer. Additionally, Mia Femtech provides minimally invasive breast harmony solutions. Supported by over 200 patent applications and 50 scientific studies, their offerings are grounded in science-based innovation. The company operates in multiple regions, including Costa Rica, Brazil, and Belgium, targeting healthcare providers and patients in the medical and aesthetic sectors.
Establishment Labs offers Motiva SmoothSilk Round, Motiva SmoothSilk Ergonomix, Motiva Flora Tissue Expander, and Mia Femtech.
Yes, Establishment Labs is publicly traded on NASDAQ under the ticker symbol ESTA.
Establishment Labs has 6 investors. Key investors include Perceptive Advisors, Madryn Asset Management, Crown Predator Holdings, JW Asset Management, and Rio Technology Partners.
Establishment Labs operates through Establishment Labs Holdings Inc..